New drug development for neglected diseases: a bibliometric analysis

• Autor(a) principal: Neto, Paula Teixeira Pinto Ferreira
• Data de Publicação: 2022
• Outros Autores: dos Santos, Taís Rubia, Vargas, Marco Antonio, Maldonado, Jose Manuel Santos de Varge
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: RECIIS (Online)
• Texto Completo: https://www.reciis.icict.fiocruz.br/index.php/reciis/article/view/2380
• topic: Drug development; Drug design; Scientific research and technological development; Neglected diseases; Bibliometrics.; Desarrollo de medicamentos; Diseño de fármacos; Investigación científica y desarrollo tecnológico; Enfermedades desatendidas; Bibliometría.; Desenvolvimento de medicamentos; Desenho de fármacos; Pesquisa científica e desenvolvimento tecnológico; Doenças negligenciadas; Bibliometria.

Neglected diseases impose a devastating human, social, and economic burden on more than one billion people worldwide. While tools exist to control and even eliminate many of these diseases, new therapeutic products urgently need to be developed. This article is based on a study that sought to quantify and characterize the global scientific production on new drug development for neglected diseases through a bibliometric analysis. The Scopus database was used to investigate the research related to the development of new drugs for neglected diseases globally in the last decade. An increase in the production of knowledge about the theme and the relevant participation of Brazilian authors, institutions and funding, especially from public institutions were observed. However, their efforts have been insufficient, and the implementation of future research and funding strategies that provide greater scientific production and a translation of basic research into clinical practice is necessary.